Literature DB >> 25552465

Structural and functional alterations of the right ventricle are common in adults operated for ventricular septal defect as toddlers.

Johan Heiberg1, Steffen Ringgaard2, Michael Rahbek Schmidt3, Andrew Redington4, Vibeke Elisabeth Hjortdal5.   

Abstract

AIMS: Patients with a surgically closed ventricular septal defect (VSD) contribute significantly to the increasing number of adults with congenital heart disease. The chronic effects of prior adverse haemodynamics in this population are incompletely understood. Our objective was to assess postoperative cardiac function and morphology in adult survivors of surgery in childhood. METHODS AND
RESULTS: Patients (n = 27), median surgical age of 1.9 (95% CI 1.1-2.8 years) and 20.5 (95% CI 19.6-22.1 years) at the time of examination, and age-matched controls (n = 28) underwent cardiac magnetic resonance imaging. We performed offline analyses of biventricular cardiac deformations, myocardial mass indices, flow patterns, and chamber areas and dimensions. In comparison with controls, VSD-operated patients had higher right ventricular (RV) areas; 36.8 ± 9.0 vs. 30.4 ± 6.4 cm(2) in end-diastole, P < 0.01, and 21.3 ± 5.9 vs. 16.0 ± 3.9 cm(2) in end-systole, P < 0.01. Furthermore, we found that fractional area change was lower among VSD-operated patients compared with controls; 0.42 ± 0.07 vs. 0.47 ± 0.05, P < 0.01, and we demonstrated a higher RV mass index in the VSD cohort compared with controls, P < 0.01. Radial strain was higher in the VSD group compared with controls; 30.2 ± 10.4 vs. 22.4 ± 7.7%, P < 0.01, whereas no difference was found in longitudinal strain; -20.1 ± 3.8% among VSD-operated patients vs. -21.5 ± 4.7% among controls, P = 0.28.
CONCLUSION: Left ventricular function is normal, but changes in RV structure and function are demonstrable 20 years after surgical closure of VSD. The mechanisms and implications for these findings justify a further study in this increasingly large population of adult survivors of early surgery. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Adults with congenital heart disease; Cardiac magnetic imaging; Ventricular septal defect

Mesh:

Year:  2014        PMID: 25552465     DOI: 10.1093/ehjci/jeu292

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  4 in total

1.  Longitudinal Deformation of the Right Ventricle in Hypoplastic Left Heart Syndrome: A Comparative Study of 2D-Feature Tracking Magnetic Resonance Imaging and 2D-Speckle Tracking Echocardiography.

Authors:  Mona Salehi Ravesh; Carsten Rickers; Finn Jonathan Bannert; David Hautemann; Abdullah Al Bulushi; Dominik Daniel Gabbert; Philip Wegner; Eva Kis; Jan Hinnerk Hansen; Michaeal Jerosch-Herold; H-H Kramer; Jana Logoteta
Journal:  Pediatr Cardiol       Date:  2018-05-10       Impact factor: 1.655

2.  The prognostic value of right ventricular deformation derived from cardiac magnetic resonance tissue tracking for all-cause mortality in light-chain amyloidosis patients.

Authors:  Hui Liu; Hang Fu; Ying-Kun Guo; Zhi-Gang Yang; Hua-Yan Xu; Xiao Shuai; Rong Xu; Zhen-Lin Li; Chun-Chao Xia; Yong He; Xiao-Yue Zhou
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

3.  Minimally-invasive-perventricular-device-occlusion versus surgical-closure for treating perimembranous-ventricular-septal-defect: 3-year outcomes of a multicenter randomized clinical trial.

Authors:  Wenxin Lu; Fengwen Zhang; Taibing Fan; Tianli Zhao; Yu Han; Xiaopeng Hu; Qi Li; Hao Shi; Xiangbin Pan
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

4.  Health-related quality of life in children and adolescents undergoing intraoperative device closure of isolated perimembranous ventricular septal defects in southeastern China.

Authors:  Jiang-Shan Huang; Shu-Ting Huang; Kai-Peng Sun; Zhi-Nuan Hong; Liang-Wan Chen; Yur-Ren Kuo; Qiang Chen
Journal:  J Cardiothorac Surg       Date:  2019-12-16       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.